Home >> News >> Business >> Global Multiplexed Diagnostics market report just published by Credence Research Inc.

Global Multiplexed Diagnostics market report just published by Credence Research Inc.

The purpose of the report is to illustrate the state of the market of Blood Processing Devices and Consumables, to present actual information about the volumes of production, exports, imports, consumption and the state of the market, the changes that took place in 2017, and also, to build a forecast for the growth of the industry in the medium term until 2026. [Continue Reading]

Market Insights:

Multiplexed assays are capable of measuring multiple analytes in a single cycle of an assay. Multiplexed diagnostics are utilized in detection of different analytes and aid in the diagnosis of specific diseases including cancers, autoimmune disease, and cardiovascular disease. The number of analytes screened in single assay depends on the technology of the multiplex equipment and ranges from 5 to 10,000 analytes. Timely diagnosis of the infectious diseases can minimize the risk associated with it and aids in the proper treatment of the disease. Increased prevalence of cancers and other infectious diseases along with established advantages of multiplexed diagnostics are contributing to the surge of the market.

Increased funding in the field of personalized medicine and genomics, and emerging demand for advanced diagnostic technologies for cancers and other infectious diseases are driving the global multiplexed diagnostics market. Other factors leading to market escalation include increased rate of research in institutes and adoption of these techniques in pharmaceutical developments. However, lack of skilled technicians to operate these equipment and high costs are affecting the global multiplexed diagnostics market..

Leading Players: Agilent Technologies, BioMérieux SA, Bio-Rad Laboratories, F. Hoffmann-La Roche Ltd., Hologic, Inc., Illumina, Inc., Luminex Corporation, Siemens Healthineers, Abbott Laboratories, and Thermo Fisher Scientific, Inc..

Browse here for full report with Toc: https://www.credenceresearch.com/report/multiplexed-diagnostics-market

Why was the report written?

This report is the result of an extensive survey drawn from Credence Research’s exclusive panel of leading global market industry executives; it provides data and analysis on buyer investment, acquisition, and developments within the global market research. It includes key topics such as global Multiplexed Diagnostics buyer expenditure and procurement behaviors and strategies and recognizes the threats and possibilities within the industry, economic outlook trends, and business confidence within global industry executives. Most secondary research reports are based on general industry drivers and do not understand the industry executives’ attitude and changing behaviors, creating a gap in presenting the business outlook of the industry; in an effort to bridge this gap, Credence Research created this primary research-based report by gathering the opinions of multiple stakeholders in the value chain of the global industry. [Continue Reading]

What is the current market landscape and what is changing?

Executives from the global industry anticipate an increase in levels of consolidation, with 55% of respondents projecting an increase in merger and acquisition (M&A) activities in 2017.

The report on the market of Multiplexed Diagnostics contains:

Analysis and forecast of Multiplexed Diagnostics market dynamics;

Analysis of domestic production, market shares of the main market players;

Analysis of exports and imports;

Analysis of factors, leading the development of the Multiplexed Diagnostics market;

Assessment and forecast of Multiplexed Diagnostics market development;

Financial and business profiles of the leading companies in theMultiplexed Diagnostics industry.

Scope                    

– Up to date working Multiplexed Diagnostics data by major regions in the world, the forecast of planned capacity additions by 2026

– The annual breakdown of capital expenditure spending on proposed Multiplexed Diagnostics for the period 2018 to 2026

– Planned Multiplexed Diagnostics additions and capital expenditure spending by key countries and companies across the world

– Planned capital expenditure spending on new Multiplexed Diagnostics projects by region, key countries, and companies

– Details of major planned Multiplexed Diagnostics projects in the world up to 2026

Browse here for full report with Toc:https://www.credenceresearch.com/report/multiplexed-diagnostics-market

Also you can request us for sample in pdf with more details and graph:https://www.credenceresearch.com/sample-request/58930

About Us                                

Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.

Contact Us:                   

Credence Research Inc.

105 N 1st ST #429

SAN JOSE

CA 95103

United States

Toll Free (US/CANADA): +1-800-361-8290

Web: https://www.credenceresearch.com

Leave a Reply

Your email address will not be published. Required fields are marked *